Attana
0.01 SEK
-11.11 %
Less than 1K followers
ATANA
Nordic SME
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Attana
EV/S
Median 2019-2022
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 0.40 | 0.94 | 0.37 | 0.10 | 0.06 | 0.01 | 0.01 |
| Shares | 270.9 | 354.7 | 435.1 | 419.2 | 483.7 | 1,379.2 | 2,580.6 |
| Market cap | 107.5 | 334.1 | 159.1 | 41.6 | 27.0 | 8.3 | 23.2 |
| Enterprise value | 106.9 | 300.5 | 148.3 | 44.9 | - | - | - |
| EV/S | 16.5 | 71.8 | 92.7 | 5.9 | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | neg. | - | - | - |
| EV/EBIT | neg. | neg. | neg. | neg. | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 7.36 | 7.01 | 5.13 | 2.56 | 1.46 | 0.46 | 1.22 |
| P/S | 16.6 | 79.9 | 99.4 | 5.5 | 5.3 | 2.0 | 9.4 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 73.2 % | 79.8 % | 84.1 % | 55.7 % | 56.0 % | 73.8 % | 78.6 % |
| Gearing ratio | 22.0 % | 8.3 % | 7.2 % | 20.2 % | 16.9 % | 15.1 % | 11.6 % |